3D Global Biotech (ROCO:6808) Debt-to-Equity : 0.02 (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech Debt-to-Equity?

3D Global Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$6.10 Mil. 3D Global Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was NT$1.02 Mil. 3D Global Biotech's Total Stockholders Equity for the quarter that ended in Jun. 2024 was NT$457.04 Mil. 3D Global Biotech's debt to equity for the quarter that ended in Jun. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for 3D Global Biotech's Debt-to-Equity or its related term are showing as below:

ROCO:6808' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.04 Max: 0.06
Current: 0.02

During the past 7 years, the highest Debt-to-Equity Ratio of 3D Global Biotech was 0.06. The lowest was 0.00. And the median was 0.04.

ROCO:6808's Debt-to-Equity is ranked better than
88.39% of 1025 companies
in the Biotechnology industry
Industry Median: 0.14 vs ROCO:6808: 0.02

3D Global Biotech Debt-to-Equity Historical Data

The historical data trend for 3D Global Biotech's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech Debt-to-Equity Chart

3D Global Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.01

0.05

0.06

0.05

0.04

3D Global Biotech Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Debt-to-Equity	Get a 7-Day Free Trial								0.06	0.05	0.04	0.04	0.02

Competitive Comparison of 3D Global Biotech's Debt-to-Equity

For the Biotechnology subindustry, 3D Global Biotech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3D Global Biotech's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Global Biotech's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where 3D Global Biotech's Debt-to-Equity falls into.

3D Global Biotech Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

3D Global Biotech's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.297	+	4.082)	/	293.467
	=	0.04

3D Global Biotech's Debt to Equity Ratio for the quarter that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.097	+	1.024)	/	457.042
	=	0.02

3D Global Biotech (ROCO:6808) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

3D Global Biotech Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Global Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Section 1, Xintai 5th Road, 21st Floor -3, Xizhi District, New Taipei, TWN, 221

Website

http://www.3dglobalbiotech.com.tw

3D Global Biotech Inc is engaged in developing reconstruction of human tissues and organs and manufactures customized and personalized high-level medical devices.

3D Global Biotech Headlines

No Headlines